Published in Neurourol Urodyn on March 30, 2012
Re: Petros, P. An anatomical explanation for "urodynamic features and artifacts". Neurourol Urodyn 2014; 33:153-4. Neurourol Urodyn (2013) 2.01
Re: Gammie, A. re: an anatomical explanation for "urodynamic features and artifacts". Neurourol Urodyn 2014; 33:155. Neurourol Urodyn (2013) 1.20
Work Capacity of the Bladder During Voiding: A Novel Method to Evaluate Bladder Contractile Function and Bladder Outlet Obstruction. Chin Med J (Engl) (2015) 0.79
Detrusor after-contraction: a new insight. Int Braz J Urol (2015) 0.75
Typical Value Ranges and Typical Signal Patterns in the Initial Cough in Patients With Neurogenic Bladder: Quality Control in Urodynamic Studies. Int Neurourol J (2016) 0.75
Re: Hogan S, Gammie A, Abrams P. Urodynamic features and artifacts. Neurourol urodyn 2012; 31:1104-1117. Neurourol Urodyn (2013) 0.75
Clinical evaluation of a high-fidelity wireless intravaginal pressure sensor. Int Urogynecol J (2014) 0.75
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 22.80
Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn (2002) 8.01
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol (2006) 7.13
ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn (2004) 5.31
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol (2002) 4.31
Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int (2011) 3.28
Tolterodine treatment improves storage symptoms suggestive of overactive bladder in men treated with alpha-blockers. Eur Urol (2008) 2.58
The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 2.46
Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol (2008) 2.41
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder. Eur Urol (2009) 2.33
A new classification is needed for pelvic pain syndromes--are existing terminologies of spurious diagnostic authority bad for patients? J Urol (2006) 2.13
EAU guidelines on urinary incontinence. Eur Urol (2010) 2.10
The immediate and 6-mo reproducibility of pressure-flow studies in men with benign prostatic enlargement. Eur Urol (2007) 2.03
A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management--a systematic review and meta-analysis. Eur Urol (2012) 1.81
Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 2: Noninvasive urodynamics and combination of measures. J Urol (2006) 1.77
The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder. Eur Urol (2006) 1.77
How should patients with an overactive bladder manipulate their fluid intake? BJU Int (2008) 1.70
Ultrasound estimated bladder weight and measurement of bladder wall thickness--useful noninvasive methods for assessing the lower urinary tract? J Urol (2010) 1.67
Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol (2008) 1.62
Noninvasive techniques for the measurement of isovolumetric bladder pressure. J Urol (2004) 1.58
Risk of tape-related complications after TVT is at least 4%. Neurourol Urodyn (2010) 1.52
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int (2006) 1.50
The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. BJOG (2002) 1.50
Validity of the international consultation on incontinence questionnaire-pediatric lower urinary tract symptoms: a screening questionnaire for children. J Urol (2010) 1.48
Automatic evaluation of ultrasonography-estimated bladder weight and bladder wall thickness in community-dwelling men with presumably normal bladder function. BJU Int (2011) 1.45
Can maximum urethral closure pressure (MUCP) be used to predict outcome of surgical treatment of stress urinary incontinence? Neurourol Urodyn (2011) 1.44
What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trial. Int Urogynecol J (2011) 1.41
Flow meter urine testing: a practical proposition in patients attending for urodynamics? BJU Int (2006) 1.40
The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study. Eur J Obstet Gynecol Reprod Biol (2011) 1.39
Development and validation of the Overactive Bladder Satisfaction (OAB-S) Questionnaire. Neurourol Urodyn (2008) 1.26
Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence. BJOG (2004) 1.24
Overactive bladder and painful bladder syndrome: there need not be confusion. Neurourol Urodyn (2005) 1.23
A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol (2004) 1.23
Surgical treatment of stress incontinence in men. Neurourol Urodyn (2010) 1.23
Urogenital pain--time to accept a new approach to phenotyping and, as a consequence, management. Eur Urol (2007) 1.19
Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int (2008) 1.12
Overactive bladder: an update. Curr Opin Urol (2007) 1.08
Editorial comment: Re: Brubaker L. Conflict of interest: what is the role of our professional societies? Neurourol Urodyn 2012;31:1217-1218. Neurourol Urodyn (2012) 1.08
Development and validation of a quality-of-life measure for men with nocturia. Urology (2004) 1.07
Access to every trial dataset is crucial. BMJ (2004) 1.06
Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ (2002) 1.06
Suprapubic catheter insertion is an outpatient procedure: cost savings resultant on closing an audit loop. BJU Int (2008) 1.05
The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol (2005) 1.03
Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach. J Urol (2006) 1.03
The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated bladder outlet obstruction. BJU Int (2005) 1.00
Technique of urethral retro-resistance pressure measurement. Neurourol Urodyn (2004) 1.00
Overactive bladder is associated with erectile dysfunction and reduced sexual quality of life in men. J Sex Med (2008) 0.95
Persistent detrusor overactivity after transurethral resection of the prostate. Curr Urol Rep (2008) 0.95
What are the causes and consequences of bladder overdistension? ICI-RS 2011. Neurourol Urodyn (2012) 0.95
Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations. Drugs (2004) 0.94
The extent and severity of urinary incontinence amongst women in UK GP waiting rooms. Fam Pract (2006) 0.93
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int (2006) 0.92
Can we prevent incontinence? ICI-RS 2011. Neurourol Urodyn (2012) 0.91
A patient-centered approach to developing a comprehensive symptom and quality of life assessment of anal incontinence. Dis Colon Rectum (2007) 0.90
The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder. J Urol (2003) 0.90
Benign prostatic hyperplasia: The term BPH is misused. BMJ (2008) 0.89
Natural history of detrusor contractility--minimum ten-year urodynamic follow-up in men with bladder outlet obstruction and those with detrusor. Scand J Urol Nephrol Suppl (2004) 0.89
Psychometric evaluation of a new patient-completed questionnaire for evaluating anal incontinence symptoms and impact on quality of life: the ICIQ-B. Dis Colon Rectum (2011) 0.88
Cure sometimes, help always--a "continence paradigm" for all ages and conditions. Neurourol Urodyn (2006) 0.88
Does the patient's position influence the detection of detrusor overactivity? Neurourol Urodyn (2008) 0.88
Efficacy and tolerability of tolterodine extended release in male and female patients with overactive bladder. Eur Urol (2006) 0.86
Urinary diaries: evidence for the development and validation of diary content, format, and duration. Neurourol Urodyn (2011) 0.86
Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance? Neurourol Urodyn (2008) 0.85
The 50-year history of the ice water test in urology. J Urol (2010) 0.85
The validation of a functional, isolated pig bladder model for physiological experimentation. Front Pharmacol (2012) 0.84
Recognition and effective management of autonomic dysreflexia in spinal cord injuries. Expert Opin Pharmacother (2007) 0.83
Transurethral prostate resection, noncontact laser therapy or conservative management in men with symptoms of benign prostatic enlargement? An economic evaluation. J Urol (2002) 0.83
Defining achievable standards in urodynamics-a prospective study of initial resting pressures. Neurourol Urodyn (2012) 0.83
Impact of surgical treatment on nocturia in men with benign prostatic obstruction. BJU Int (2006) 0.83
Desmopressin, as a "designer-drug," in the treatment of overactive bladder syndrome. Neurourol Urodyn (2009) 0.82
The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic follow-up of untreated detrusor underactivity. BJU Int (2005) 0.81
Nocturia: new directions. Neurourol Urodyn (2011) 0.81
Lower urinary tract symptom: still too much focus on the prostate? Curr Opin Urol (2014) 0.80
Efficacy and safety of tolterodine extended-release in men with overactive bladder symptoms treated with an α-blocker: effect of baseline prostate-specific antigen concentration. BJU Int (2010) 0.80
How does neuromodulation work. Neurourol Urodyn (2011) 0.80
Emerging drugs for the treatment of benign prostatic obstruction. Expert Opin Emerg Drugs (2010) 0.80
The future of urology. Eur Urol (2011) 0.79
Management of the overactive bladder: a review of pharmacological therapies and methods used by the urological specialist. Can J Urol (2007) 0.79
Synthetic vaginal tapes for stress incontinence: proposals for improved regulation of new devices in Europe. Eur Urol (2011) 0.78
The unstable detrusor. Urol Int (2004) 0.78
Pharmacological management of women with mixed urinary incontinence. Drugs (2006) 0.78
The long-term natural history of overactive bladder symptoms due to idiopathic detrusor overactivity in women. BJU Int (2009) 0.78
Ultrasound estimated bladder weight in men attending the uroflowmetry clinic. Neurourol Urodyn (2011) 0.78
New therapies in the treatment of overactive bladder. Expert Opin Emerg Drugs (2013) 0.78
The use of ultrasound-estimated bladder weight in diagnosing bladder outlet obstruction and detrusor overactivity in men with lower urinary tract symptoms. Indian J Urol (2009) 0.78
3rd International Consultation on Incontinence--Research Society 2011. Neurourol Urodyn (2012) 0.77
Developing a validated urinary diary: phase 1. Neurourol Urodyn (2012) 0.77
Future directions in pelvic neuromodulation. Urol Clin North Am (2005) 0.76
The impact of formal education and training on urodynamic practice in the United Kingdom: a survey. Neurourol Urodyn (2006) 0.76
Prostate surgery to improve sleep quality: the key to success? (Related to: Hernández C. et al. Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Curr Med Res Opin 2008 Apr;24(4):1033-8). Curr Med Res Opin (2010) 0.75
Letter to the editor: conflicts of interest. Neurourol Urodyn (2008) 0.75
New Medical Education Standards Board will lower standards. BMJ (2002) 0.75
Nocturia: escaping the "prostate-centric" approach. J Urol (2011) 0.75
Editorial comment. J Urol (2012) 0.75
A simple method for teaching about voiding disorders. BJU Int (2006) 0.75
Prevalence of urinary incontinence in women determined using the BFLUTS questionnaire. Neurourol Urodyn (2003) 0.75
Absolute versus relative pressure. Neurourol Urodyn (2009) 0.75